1. Editorial: Celebrating the 200th mendel’s anniversary: gene-targeted diagnostics and therapies for cancer
   Noah Federman et al, 2024, Frontiers in Molecular Medicine CrossRef
2. Antileukemic Effects of Anti-miR-146a, Anti-miR-155, Anti-miR-181a, and Prednisolone on Childhood Acute Lymphoblastic Leukemia
   Burak Durmaz et al, 2021, BioMed Research International CrossRef
3. p53/NF-kB Balance in SARS-CoV-2 Infection: From OMICs, Genomics and Pharmacogenomics Insights to Tailored Therapeutic Perspectives (COVIDomics)
   Daniela Milani et al, 2022, Frontiers in Pharmacology CrossRef
4. The advent of a pan-collagenous CLOVIS POINT for pathotropic targeting and cancer gene therapy, a retrospective
   Erlinda M. Gordon et al, 2023, Frontiers in Molecular Medicine CrossRef
5. Silencing the Expression of Cyclin G1 Enhances the Radiosensitivity of Hepatocellular Carcinoma In Vitro and In Vivo by Inducing Apoptosis
   Gang Xu et al, 2021, Radiation Research CrossRef
6. Ruthenium(II) Phosphine/Mercapto Complexes: Their in Vitro Cytotoxicity Evaluation and Actions as Inhibitors of Topoisomerase and Proteasome Acting as Possible Triggers of Cell Death Induction
   Gabriel H. Ribeiro et al, 2020, Inorganic Chemistry CrossRef
7. Identification of common microRNA between COPD and non-small cell lung cancer through pathway enrichment analysis
   Amirhossein Fathinavid et al, 2021, BMC Genomic Data CrossRef
8. Tumor protein p53 mutation in archived tumor samples from a 12‑year survivor of stage 4 pancreatic ductal adenocarcinoma may predict long‑term survival with DeltaRex‑G: A case report and literature review
   Michael Morse et al, 2021, Molecular and Clinical Oncology CrossRef
9. Phase I-II study using DeltaRex-G, a tumor-targeted retrovector encoding a cyclin G1 inhibitor for metastatic carcinoma of breast
   Howard W. Bruckner et al, 2023, Frontiers in Molecular Medicine CrossRef
10. Evaluation of the p53 pathway in polycystic ovarian syndrome pathogenesis and apoptosis enhancement in human granulosa cells through transcriptome data analysis
    M. Zanjirband et al, 2023, Scientific Reports CrossRef
11. Immune and Cell Cycle Checkpoint Inhibitors for Cancer Immunotherapy
    Erlinda M. Gordon et al, 2021, Advances in Precision Medicine Oncology CrossRef
12. Cell Cycle Regulatory Protein Expression in Multinucleated Giant Cells of Giant Cell Tumor of Bone: do They Proliferate?
    Mate E. Maros et al, 2021, Pathology and Oncology Research CrossRef
13. Cinobufagin Induces Cell Cycle Arrest at the G2/M Phase and Promotes Apoptosis in Malignant Melanoma Cells
    Zhaohai Pan et al, 2019, Frontiers in Oncology CrossRef
14. Parallel global profiling of plant TOR dynamics reveals a conserved role for LARP1 in translation
    M Regina Scarpin et al, 2020, eLife CrossRef
15. Ruthenium(II) Diphosphine Complexes with Mercapto Ligands That Inhibit Topoisomerase IB and Suppress Tumor Growth In Vivo
    Monize M. da Silva et al, 2021, Inorganic Chemistry CrossRef
16. Three year results of Blessed: Expanded access for DeltaRex-G for an intermediate size population with advanced pancreatic cancer and sarcoma (NCT04091295) and individual patient use of DeltaRex-G for solid malignancies (IND# 19130)
    Sant P. Chawla et al, 2022, Frontiers in Molecular Medicine CrossRef
17. In vivo assessment of simultaneous G1 cyclins silencing by a tumor-specific bidirectional promoter on the mammary tumor in nude mice
    Gholamreza Mesbah et al, 2022, Frontiers in Veterinary Science CrossRef
18. Silencing CCNG1 protects MPC-5 cells from high glucose-induced proliferation-inhibition and apoptosis-promotion via MDM2/p53 signaling pathway
    Ye Chen et al, 2020, International Urology and Nephrology CrossRef
19. Nimbolide Represses the Proliferation, Migration, and Invasion of Bladder Carcinoma Cells via Chk2-Mediated G2/M Phase Cell Cycle Arrest, Altered Signaling Pathways, and Reduced Transcription Factors-Associated MMP-9 Expression
    Seung-Shick Shin et al, 2019, Evidence-Based Complementary and Alternative Medicine CrossRef
20. Anticancer effects of brusatol in nasopharyngeal carcinoma through suppression of the Akt/mTOR signaling pathway
    Songbin Guo et al, 2020, Cancer Chemotherapy and Pharmacology CrossRef
21. Small-Molecule Gankyrin Inhibition as a Therapeutic Strategy for Breast and Lung Cancer
    Dipti Kanabar et al, 2022, Journal of Medicinal Chemistry CrossRef
22. Cyclin-Dependent Kinase as a Novel Therapeutic Target: An Endless Story
    Ahmed Mohamed Etman et al, 2021, Current Chemical Biology CrossRef
23. Our Journey Beyond Sunset Boulevard: Evidence-Based Analysis of Tumor-Targeted Cancer Gene Therapy Shines a Critical Spotlight on Long-Term Cancer-Free Survival
    Frederick L. Hall et al, 2021, Our Journey Beyond Sunset Boulevard - Evidence-based Analysis of Tumor-Targeted Gene- and Immuno-Therapies Shine a Critical Spotlight on “True” Long-Term Cancer-Free Survival CrossRef
24. Auxiliary effect of trolox on coenzyme Q10 restricts angiogenesis and proliferation of retinoblastoma cells via the ERK/Akt pathway
    Shikha Upreti et al, 2024, Scientific Reports CrossRef